Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: Acquisition versus consolidation

Psychopharmacology

Volumn 177, Issue 4, 2005, Pages 381-390

  Prickaerts, Jos ^a,b   Şık, Ayhan ^a   Van Der Staay, Franz Josef ^c   De Vente, Jan ^a   Blokland, Arjan ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Johnson Johnson P   (Belgium)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acetylcholinesterase; Acquisition; Consolidation; Memory; Object; Phosphodiesterase

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; METRIFONATE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; LEARNING; MEMORY; MEMORY CONSOLIDATION; METABOLIC CLEARANCE RATE; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION;

EID: 13644264832     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1967-7     Document Type: Article

References (56)

1. Abel T, Lattal KM (2001) Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol 11:180-187
2. Baratti CM, Boccia MM (1999) Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 10:731-737
3. Baratti CM, Kopf SR (1996) The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent. Neurobiol Learn Mem 65:121-124
4. Bejar C, Wang RH, Weinstock M (1999) Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 383:231-240
5. Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH (1996) Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. NeuroReport 7:585-588
6. Bernabeu R, Schroder N, Quevedo J, Cammarota M, Izquierdo I, Medina JH (1997) Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. NeuroReport 8:2221-2224
7. Blokland A (1996) Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21:285-300
8. Bussey TJ, Muir JL, Aggleton JP (1999) Functionally dissociating aspects of event memory: the effects of combined perirhinal and postrhinal cortex lesions on object and place memory in the rat. J Neurosci 19:495-502
9. Camacho F, Smith CP, Vargas HM, Winslow JT (1996) Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat. Psychopharmacology 124:347-354
10. Chen Z, Xu AJ, Li R, Wei EQ (2002) Reversal of scopolamine-induced spatial memory deficits in rats by TAK-1471. Acta Pharmacol Sin 23:355-360
11. Cheng DH, Tang XC (1998) Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol Biochem Behav 60:377-386
12. Chopin P, Colpaert FC, Marien M (2002) Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. J Pharmacol Exp Ther 301:187-196
13. De Vente J, Hopkins DA, Markerink-van Ittersum M, Steinbusch HWM (1996) Effects of the 3′,5′-phosphodiesterase inhibitors isobutylmethylxanthine and zaprinast on NO-mediated cGMP accumulation in the hippocampus slice preparation: an immunocytochemical study. J Chem Neuroanat 10:241-248
14. Dundore RL, Clas DM, Wheeler LT, Habeeb PG, Bode DC, Buchholz RA, Silver PJ, Pagani ED (1993) Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. Eur J Pharmacol 249:293-297
15. Ennaceur A, Aggleton JP (1997) The effect of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav Brain Res 88:181-193
16. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47-59
17. Ennaceur A, Meliani K (1992) Effects of physostigmine and scopolamine on rats's performances in object-recognition and radial-maze tests. Psychopharmacology 109:321-330
18. FDA (1998) Viagra tablets (sildenafil citrate). Review and evaluation of pharmacology and toxicology data. Report from the Division of Cardio-renal Drug Products (HFD-10), Center for Drug Evaluation and Research. Food and Drug Administration, Washington, pp 121-122
19. Hinz V, Grewig S, Schmidt BH (1996a) Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood. Neurochem Res 21:339-345
20. Hinz VC, Blokland A, Van der Staay FJ, Gebert I, Schuurman T, Schmidt BH (1996b) Receptor interaction profile and CNS general pharmacology of metrifonate and its transformation product dichlorvos in rodents. Drug Dev Res 38:31-42
21. Ikonen S, Schmidt BH, Riekkinen P Jr (1999) Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice. Eur J Pharmacol 372:117-126
22. Itoh A, Nitta A, Katono Y, Usui M, Naruhashi K, Iida R, Hasegawa T, Nabeshima T (1997) Effects of metrifonate on memory impairment and cholinergic dysfunction in rats. Eur J Pharmacol 322:11-19
23. Izquierdo I (1989) Different forms of post-training processing. Behav Neural Biol 51:172-202
24. Kojima J, Nakajima K, Ochiai M, Nakayama K (1997) Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia. Methods Find Exp Clin Pharmacol 19:245-251
25. Moser PC, Bergis OE, Jegham S, Lochead A, Duconseille E, Terranova JP, Caille D, Berque-Bestel I, Lezoualc'h F, Fischmeister R, Dumuis A, Bockaert J, George P, Soubrie P, Scatton B (2002) SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J Pharmacol Exp Ther 302:731-741
26. Mumby DG (2001) Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats. Behav Brain Res 127:159-181
27. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H (2002) Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem 9:49-57
28. Ogasawara T, Itoh Y, Tamura M, Ukai Y, Yoshikuni Y, Kimura K (1996) NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Pharmacol Biochem Behav 53:391-399
29. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000) Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Find Exp Clin Pharmacol 22:89-95
30. Prickaerts J, Steinbusch HWM, Smits JFM, De Vente J (1997) Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol 337:125-136
31. Prickaerts J, De Vente J, Honig W, Steinbusch HWM, Blokland A (2002a) Cyclic GMP, but not cyclic AMP, in rat hippocampus is involved in early stages of object memory consolidation. Eur J Pharmacol 436:83-87
32. Prickaerts J, Van Staveren WCG, Sik A, Markerink-Van Ittersum M, Niewöhner U, Van der Staay FJ, Blokland A, De Vente J (2002b) Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 113:349-359
33. Prickaerts J, Sik A, Van Staveren WCG, Koopmans G, Steinbusch HWM, Van der Staay FJ, De Vente J, Blokland A (2004) Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int (in press)
34. Rehse K, Scheffler H, Reitner N (1999) Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities. Arch Pharm (Weinheim) 332:182-184
35. Riekkinen M, Riekkinen P Jr (1994) Effects of THA and physostigmine on spatial navigation and avoidance performance in mecamylamine and PCPA-treated rats. Exp Neurol 125:111-118
36. Riekkinen P Jr, Sirvio J, Riekkinen M, Riekkinen P (1991) Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis+frontal cortex-lesioned rats. Pharmacol Biochem Behav 39:841-846
37. Riekkinen PJ, Schmidt B, Stefanski R, Riekkinen M, Kuitunen J, Riekkinen M (1996) Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats. Eur J Pharmacol 309:121-130
38. Riekkinen P Jr, Schmidt BH, van der Staay FJ (1998) Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease. Ann Med 30:566-576
39. Santucci AC, Kanof PD, Haroutunian V (1989) Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Psychopharmacology 99:70-74
40. Scali C, Giovannini MG, Bartolini L, Prosperi C, Hinz V, Schmidt B, Pepeu G (1997a) Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur J Pharmacol 325:173-180
41. Scali C, Giovannini MG, Prosperi C, Bartolini L, Pepeu G (1997b) Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res 36:463-469
42. Schmidt BH, De Jonge M (1991) Behavioral and biochemical studies on metrifonate: a novel putative alzheimer therapeutic. Biol Psychiatry 29(Suppl 1):486S
43. Schmidt HHHW, Lohmann SM, Walter U (1993) The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178:153-175
44. Şik A, Van Nieuwehuyzen P, Prickaerts J, Blokland A (2003) Performance of different mouse strains in an object recognition task. Behav Brain Res 147:49-54
45. Smith RD, Grzelak ME, Belanger B, Morgan CA (1996) The effects of tropicamide on mydriasis in young rats exhibiting a natural deficit in passive-avoidance responding. Life Sci 59:753-760
46. Suzuki M, Yamaguchi T, Ozawa Y, Ohyama M, Yamamoto M (1995) Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice. J Pharmacol Exp Ther 275:728-736
47. Tokita K, Yamazaki S, Yamazaki M, Matsuoka N, Mutoh S (2002) Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats. Pharmacol Biochem Behav 73:511-519
48. Van der Staay FJ, Hinz VC, Schmidt BH (1996) Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats. J Pharmacol Exp Ther 278:697-708
49. Van Staveren WCG, Markerink-Van Ittersum M, Steinbusch HWM, De Vente J (2001) The effect of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res 888:275-286
50. Staveren WCG, Steinbusch HWM, Markerink-Van Ittersum M, Repaske DR, Goy MF, Kotera J, Omori K, Beavo JA, De Vente J (2003) mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterase types 2, 5 and 9 during development of the brain. J Comp Neurol 467:566-580
51. Walker DK, Ackland MJ, James GC, Muirhead GJ, Rance DJ, Wastall P, Wright PA (1999) Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29:297-310
52. Wei JY, Roy DS, Leconte L, Barnstable CJ (1998) Molecular and pharmacological analysis of cyclic nucleotide-gated channel function in the central nervous system. Prog Neurobiol 56:37-64
53. Yamazaki N, Kato K, Kurihara E, Nagaoka A (1991) Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats. Psychopharmacology 103:215-222
54. Yoshida S, Suzuki N (1993) Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. Eur J Pharmacol 250:117-124
55. Zarrindast MR, Lahiji P, Shafaghi B, Sadegh M (1998) Effects of GABAergic drugs on physostigmine-induced improvement in memory acquisition of passive avoidance learning in mice. Gen Pharmacol 31:81-86
56. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, Chopp M (2002) Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33:2675-2680